Cambridge Research Biochemicals

What Cambridge Research Biochemicals does

Cambridge Research Biochemicals (CRB) is a private US-headquartered producer of custom-made peptide and antibody tools, founded in 1980 and operating from Cleveland, USA with a workforce of 11-50 employees. The firm serves life science research customers requiring tailored peptide and antibody synthesis services, occupying a specialist custom-services niche rather than producing commodity catalog reagents. The 'leading independent' positioning in its firmographic description and 45-year operational history imply long-standing relationships with research customers and accumulated technical expertise in difficult or non-standard custom synthesis orders.

Per the available input, CRB's specific product portfolio, proprietary technologies, pricing mechanics, customer accounts, and revenue composition are not disclosed. A substantial portion of the aggregated source material describes Biosynth (biosynth.com), a separate and much larger life sciences reagent and CDMO business with related peptide capabilities but distinct corporate identity, scale, geographic footprint, and ownership. That material references proprietary technologies (CLIPS, CTAT site-specific bioconjugation, AquaSpark chemiluminescence, TrypTides), multi-continent manufacturing, and sub-brand subsidiaries (vivitide, Pepscan, celares, New England Peptide, Lifebay) that are not linked to CRB in the supplied data. No CRB-specific technology features, financial metrics, geographic footprint details, awards, partnerships, or strategic actions appear in the supplied material beyond the firmographic identifiers.

Because the supplied evidence for CRB itself is limited to firmographic descriptors, a robust investment thesis cannot be constructed from the input. The 45-year operating history and 'leading independent' positioning are consistent with an established specialty custom services vendor, but pricing, channel structure, customer mix, geographic reach, and financial trajectory are not characterized in the data. Any analysis should treat CRB-level claims — beyond what is stated in the firmographics — as unsupported by the present evidence base.

Name

Cambridge Research Biochemicals

Legal name

Biosynth Ltd

Website

https://crbdiscovery.com

Company type

Private

Founded year

2022

Operating status

Operating

Headcount range

11–50 employees

Short description

Cambridge Research Biochemicals is a private US-based independent producer of custom-made peptide and antibody tools, founded in 1980 in Cleveland, serving life science research customers with tailored synthesis services via an 11-50 employee operation.

Ownership category

akta.pro rank

Product category

Custom Peptide and Antibody Manufacturing

NAICS

In-Vitro Diagnostic Substance Manufacturing (325413), Biological Product (except Diagnostic) Manufacturing (325414), Research and Development in Biotechnology (except Nanobiotechnology) (541714)

SIC

In Vitro & In Vivo Diagnostic Substances (2835), Pharmaceutical Preparations (2834), Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Reagents, Chemicals & Assay Kits (Buffers, Antibodies, ELISA, Enzymes) (HLAGAIAI)

akta.pro secondary industries

Antibody Discovery & Engineering Platforms (display tech, bispecifics, Fc engineering) (HLAAAIAB), Protein Engineering & Directed Evolution Platforms (enzyme/therapeutic protein optimization) (HLAAAIAC), Biomarker Assay & Reagent Development (LDT/IVD assay design, antibodies/standards/controls) (HLAAAMAL)

Keywords

• Custom peptide synthesis
• Custom antibody production
• Peptide research reagents
• Antibody research tools
• Life science manufacturing

Headquarters

HQ city

Cleveland

HQ country

United States

HQ region

North America

Offices10 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Operations, Technology or R&D, Infrastructure

Revenue model

1. Catalog Products: Sale of research chemical products from extensive catalog of over one million products including bioactive small molecules, peptides, antibodies, enzymes, carbohydrates, and biological reagents
2. Custom Synthesis Services: Custom chemical synthesis, peptide synthesis, and biologics manufacturing services for pharmaceutical and life science customers
3. CDMO Manufacturing Services: Contract development and manufacturing organization services including GMP manufacturing, large-scale manufacturing, analytical services, and quality assurance
4. GMP Peptide Production: GMP-grade peptide manufacturing for clinical and commercial applications

Pricing tiers

Go-to-market motion1 record

Distribution channels3 records

Marketing channels5 records

Core offering

Cambridge Research Biochemicals is a leading independent producer of custom-made peptide and antibody tools for the life sciences industry. The company manufactures research-grade biological reagents, including custom peptides and antibodies tailored to specific customer requirements, serving research, diagnostic, and pharmaceutical applications from its Cleveland, USA facility.

Product overview

The source data provided does not contain information about Cambridge Research Biochemicals. The content is from Biosynth (biosynth.com), a different life sciences company specializing in critical raw materials, manufacturing, and services for diagnostics, vaccines, and pharmaceuticals.

Differentiator

Problem solved

Functional benefit

Brands

• vivitide: Peptide synthesis division located in Gardner, MA, USA with over 40 years of experience in complex peptide synthesis
• New England Peptide
• Pepscan
• celares
• Lifebay
• TrypTides
• Bio-X
• AquaSpark

Products and services

• Custom Peptide Synthesis
• Custom Antibody Production

Segments7 records

Ideal customer profiles1 record

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature7 records

Partnerships

One partnership is on record.

• Slovak University of Technology (STU)coreStrategic or Co-development PartnerLong-term cooperation with Slovak University of Technology (STU) in Bratislava, Slovakia for R&D support and access to academic expertise in organic synthetic chemistry.

Scale indicators4 records

Direct peers

• LifeTein: LifeTein is a US-based custom peptide and antibody synthesis provider serving academic and industrial research customers, directly comparable to CRB's custom peptide and antibody tools business.
• GenScript: GenScript is one of the largest custom gene, peptide, and antibody manufacturers globally, with discovery-through-GMP offerings that directly overlap CRB's core custom peptide and antibody services for pharma and life-science customers.
• Bio-Synthesis Inc: Bio-Synthesis provides custom oligonucleotides, peptides, and antibody services to research and diagnostic customers, making it a direct peer in the custom small-volume synthesis market served by CRB.
• Eurogentec: Eurogentec manufactures custom peptides, oligonucleotides, antibodies, and recombinant proteins for diagnostics and life-science research, overlapping CRB's biologics and peptide services for IVD and research customers.
• Mimotopes: Mimotopes specializes in custom peptide synthesis, peptide libraries, and antibody services — a near-direct peer to CRB in custom-made peptide and antibody tools for research and discovery customers.
• JPT Peptide Technologies: JPT produces custom peptides, peptide arrays, and spike-in standards for proteomics and immunopeptidomics, overlapping CRB's TrypTides proteomics standards and custom peptide offerings for life-science research customers.
• Bachem: Bachem is a leading peptide-focused CDMO offering GMP peptide manufacturing from research to commercial scale, directly comparable to CRB's discovery-to-GMP peptide pathway and its GMP peptide production capabilities.

Broad incumbents

• Thermo Fisher Scientific: Thermo Fisher is a broad incumbent life-science tools supplier offering custom peptides, antibodies, and reagents as part of a much larger portfolio, competing with CRB's catalog offerings and custom services across pharma, research, and diagnostics.
• Merck KGaA (Sigma-Aldrich): Merck's life-science division (including Sigma-Aldrich) supplies custom peptides, antibodies, and an extensive research reagent catalog, functioning as a broad incumbent competitor to CRB's catalog and custom synthesis offerings.
• Abcam: Abcam is a major antibody reagent vendor with custom antibody production capabilities, serving research and diagnostic customers with a much broader catalog — a broad incumbent peer to CRB's antibody tools business.

Market position

Strengths1 record

Weaknesses5 records

Competitive moat2 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/crb_peptides

Revenue estimate

Valuation estimate

Number of profiles

Subsidiaries6 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Cambridge Research Biochemicals